Literature DB >> 6267744

Virulence of Entamoeba histolytica in rat and its comparison with the serological responses of the amoebic patients.

V K Vinayak, S Sawhney, P Jain, S Chugh, S R Naik, R N Chakravarti.   

Abstract

The virulence of 70 isolates of Entamoeba histolytica was studied in the Wistar strain of albino rat by intracaecal inoculation of amoebae. The results were evaluated by the Neal scoring system, histopathological grading of ulcers and virulence indices. It was found that isolates from acute amoebic cases could infect and produce ulcers in significantly more animals than could the isolates from asymptomatic cyst passers. The virulence indices of isolates from acute cases were also significantly higher as compared to those from asymptomatic cyst passers. However, there was no significant difference between virulence indices of isolates from acute cases and non-dysenteric amoebic colitis. This study also showed that Neal scores failed to correlate with the type of pathology produced by the amoebae in the caecum. It is felt that virulence indices which depend upon the histopathological lesions should also be taken into consideration. The serological response of the patients tended to correlate with the virulence indices of isolates but only minimally. The results thus contradict a common belief amongst clinicians that higher levels of anti-amoebic antibodies reflect severe disease, as compared to low levels of antiamoebic antibodies.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6267744     DOI: 10.1016/0035-9203(81)90010-9

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  2 in total

1.  Specific circulating immune complexes in amoebic liver abscess.

Authors:  V K Vinayak; K Singh; K Venkatwswarlu; C K Nain; S K Mehta
Journal:  J Clin Microbiol       Date:  1986-06       Impact factor: 5.948

Review 2.  Laboratory diagnosis of amebiasis.

Authors:  Mehmet Tanyuksel; William A Petri
Journal:  Clin Microbiol Rev       Date:  2003-10       Impact factor: 26.132

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.